Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alnylam Pharmaceuticals (NQ: ALNY ) 235.76 -2.07 (-0.87%) Streaming Delayed Price Updated: 10:54 AM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 69,124 Open 239.60 Bid (Size) 235.68 (2) Ask (Size) 236.60 (5) Prev. Close 237.83 Today's Range 235.76 - 240.64 52wk Range 141.97 - 263.73 Shares Outstanding 118,847,693 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News $100 Invested In This Stock 20 Years Ago Would Be Worth $4,100 Today July 18, 2024 Via Benzinga Alnylam to Webcast Conference Call Discussing Second Quarter 2024 Financial Results July 18, 2024 From Alnylam Pharmaceuticals, Inc. Via Business Wire Performance YTD +20.95% +20.95% 1 Month +42.28% +42.28% 3 Month +61.72% +61.72% 6 Month +28.19% +28.19% 1 Year +22.59% +22.59% More News Read More Alnylam Stock Is a Blockbuster Biopharma In the Making July 18, 2024 Via InvestorPlace Peering Into Alnylam Pharmaceuticals's Recent Short Interest July 17, 2024 Via Benzinga 35% Surge Just the Beginning? Alnylam’s Stock Poised for Massive Gains on Heart Drug Success. July 11, 2024 Via InvestorPlace Peering Into Alnylam Pharmaceuticals's Recent Short Interest June 27, 2024 Via Benzinga 7 Cheap Biotech Stocks With Major Upside Potential July 09, 2024 Via InvestorPlace Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip? July 08, 2024 Via The Motley Fool EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO July 07, 2024 Via Benzinga Topics ETFs $100 Invested In Alnylam Pharmaceuticals 10 Years Ago Would Be Worth This Much Today July 03, 2024 Via Benzinga Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows July 01, 2024 Via Benzinga Topics ETFs 10 Health Care Stocks With Whale Alerts In Today's Session July 01, 2024 Via Benzinga Rivian Automotive And Carvana Were Among The 10 Biggest Large Cap Gainers Last Week (June 23-June 29): Are These In Your Portfolio? June 30, 2024 Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session June 26, 2024 Via Benzinga Nvidia, Affirm Holdings, Carnival Corp, Alnylam Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today June 24, 2024 Via Benzinga Topics Stocks Exposures US Equities Semiconductor, Nvidia Woes Deepen; Nasdaq 100 Slips, Dow Rallies; Bitcoin Sinks To $60,400: What's Driving Markets Monday? June 24, 2024 Via Benzinga Topics Stocks Exposures US Equities Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears June 24, 2024 Via InvestorPlace Exposures Product Safety Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success June 24, 2024 Via InvestorPlace Alnylam's Closely Watched Phase 3 Heart Disease Trial Of Vutrisiran Hits Primary Endpoint, Shares Surge June 24, 2024 Via Benzinga Alnylam Skyrockets After Hitting A 'Best-Case Scenario' For Heart Drug June 24, 2024 Via Investor's Business Daily RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session June 24, 2024 Via Benzinga Alnylam Reports Positive Topline Results from HELIOS-B Phase 3 Study of Vutrisiran, Achieving Statistical Significance on Primary and All Secondary Endpoints in Both Overall and Monotherapy Populations June 24, 2024 From Alnylam Pharmaceuticals, Inc. Via Business Wire Masters In Trading - Saturday, June 22 June 22, 2024 Via Talk Markets Here's How Much $1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth Today June 14, 2024 Via Benzinga $100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today June 13, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
